Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

N-acetylsarcosyl-glycyl-L-valyl-D-allo-isoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl-L-prolyl-N-ethylamide

EU orphan designation number: EU/3/03/181
Active ingredient: N-acetylsarcosyl-glycyl-L-valyl-D-allo-isoleucyl-L-threonyl-L-norvalyl-L-isoleucyl-L-arginyl-L-prolyl-N-ethylamide
Indication: Treatment of soft tissue sarcoma
Sponsor: Abbott International European Office
Abbott Laboratories Ltd, Abbott House, Norden Road, Maidenhead, Berkshire SL6 4XE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2003 Centralised Orphan - Designation EMEA/OD/059/03 (2003)5051 of 12/12/2003
19/12/2008 Centralised Orphan - Removal of orphan designation from Community Register